Commit To Buy Coherus BioSciences At $22.50, Earn 13.9% Annualized Using Options
November 09, 2015 at 11:32 AM EST
Investors considering a purchase of Coherus BioSciences Inc (CHRS) stock, but tentative about paying the going market price of $29.79/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2016 put at the $22.50 strike, which has a bid at the time of this writing of $1.65..